Late Breaking Abstract - Assessing the Clinical Benefit, Safety, and Patient-reported Outcomes with the Use of the PAHcare™ Digital Platform in Pulmonary Arterial Hypertension: A Pilot Study.

Résumé fourni par la source

Background: There are no studies on the application of digital medical products for self-care for PAH patients. PAHcare is a digital support platform with educational information. Methods: Prospective, multicentric study, with the primary outcome of evaluating PAHcare on health-related quality of life (HRQoL). Secondary outcome included disease progression, the 6-min walking test, and the patient's symptom perception. Additionally, we assessed patient satisfaction and engagement with the PAHcare™, costs, healthcare resource utilisation (HCRU), and safety. Results: Platform was evaluated in 53 patients for 6 months. Minimal, non-significant changes were observed in HRQOL and other clinical parameters. During the first month, 92% of patients used the application, and made a total of 2,912 interactions, and after 6 months, 70 % were still using it. 45% of patients completed the first level of structured training. In the first week, 76% contacted their healthcare advisor, and at the end of the study, 28% maintained contact. On average, they made almost 8 contacts per patient. 92% of patients were quite (29%) or very satisfied with the platform (63%), 68% rated the quality of service as excellent. In terms of HCRU and costs, the study showed no significant changes in PAH-related hospital admissions, clinical visits, or tests. Five patients (11%) reported PAHcare incidents, none of which were serious. Conclusions: This study offers strong evidence that the PAHcare™ digital platform is feasible and well-accepted by patients, empowering them to manage their condition and greatly improving their overall experience with PAH.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.